Medications

First generic of symbicort receives FDA approval

The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol to treat asthma in patients 6 years and older and for maintenance treatment in ...

Medications

Triple-drug therapy safely cuts serious asthma flares

Researchers have found that the inclusion of a third drug to commonly used dual-drug inhalers can reduce asthma exacerbations and improve control over the disease in children, adolescents, and adults with moderate-to-severe ...

Immunology

'Smart' asthma inhaler sensors improve pediatric asthma control

Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma—and their families—to more effectively manage this condition, according ...

Immunology

Asthma patients given risky levels of steroid tablets

More than one quarter of asthma patients have been prescribed potentially dangerous amounts of steroid tablets, with researchers warning this puts them at greater risk of serious side-effects.

Diseases, Conditions, Syndromes

Inhaler use up during coronavirus pandemic

Daily use of inhaler medication by Americans with asthma and chronic obstructive pulmonary disease (COPD) has increased during the coronavirus pandemic, a new study shows.

page 2 from 10